Synthetic analogues of growth hormone releasing peptide-6 (GHRP-6, H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2, 1, CD36 IC50 1.82 μM) have shown promising cardioprotective effects by binding and regulating CD36 in a mouse model of myocardial ischemia and reperfusion [9]. Here, CD36 is linked to myocardial ischemia.